Patents
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
07/2002
07/16/2002US6420427 Prevention and/or treatment of rheumatoid diseases, arthrosteitis, unusual bone resorption, osteoporosis, periodontitis, interstitial nephritis, arteriosclerosis, pulmonary emphysema, cirrhosis, cornea injury
07/16/2002US6420426 Used to treat complications from diabetes mellitus
07/16/2002US6420396 Biphenyl and biphenyl-analogous compounds as integrin antagonists
07/16/2002US6420302 Catalyst system
07/16/2002US6419711 Oxidation dyeing compositions containing a cationic coupling agent, novel cationic coupling agents
07/11/2002WO2002053516A2 N(phenylsulphonyl)glycine derivatives and their therapeutic use
07/11/2002WO2002008221A3 Capsaicin receptor ligands
07/11/2002WO2000072834A3 Agent for expression of long-term potentiation of synaptic transmission comprising compound having brain somatostatin activation property
07/11/2002US20020091259 Compounds useful as reversible inhibitors of cathepsin S
07/11/2002US20020091252 7-(((5-Amino-1,2,4-thiadiazol-3-yl)-(Z)-(fluormethoxyimino) -acetyl)amino)-3(E)-((imino-1-piperazinylmethyl)-methylhydrazono)methyl-3 -cephem-4-carboxylic acid trihydrochloride for example
07/11/2002US20020091210 Group 8-10 transition metal based supported catalyst where the support is treated with a pore-filling agent; improved the catalyst productivity in the presence of hydrogen
07/11/2002US20020091150 Carbamic acid derivatives
07/11/2002US20020091142 Therapeutic or prophylactic treatment of transplant rejection and inflammatory and autoimmune diseases.
07/11/2002US20020091121 Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
07/11/2002US20020091120 2-substituted heterocyclic compounds for treating multidrug resistance
07/11/2002US20020090732 Modulator for use in the treatment of brain, psychological and nervous system disorders
07/11/2002CA2434124A1 N(phenylsulphonyl)glycine derivatives and their therapeutic use
07/10/2002EP1221441A2 LTA4 Hydrolase inhibitors
07/10/2002EP1220847A2 Process for preparing benzoic acids
07/10/2002CN1358172A Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as medicament and pharmaceutical preparations containing the same
07/10/2002CN1358171A Valency platform molecules comprising aminooxy groups
07/10/2002CN1087294C Novel compounds
07/10/2002CN1087293C New amino alcohol derivatives, process for production thereof and medicaments and reagents containing these compounds
07/10/2002CN1087285C Basic group substituted benzoyl guaniazine, its preparing process, its use as medicine or diagnostic reagent, and medicine containing the same
07/10/2002CN1087283C New LH-RH antigonists with improved effectiveness
07/09/2002US6417386 Hydrazone derivatives; acarina; miticides
07/09/2002US6417162 Female impotence treated with heterocyclic compound containing nitro groups
07/04/2002WO2002051983A2 Novel compounds and compositions as cathepsin inhibitors
07/04/2002WO2002051831A1 Oxybenzamides derivatives as factor xa inhibitors
07/04/2002WO2002051824A1 Amidinophenylalanine derivatives as thrombin inhibitors
07/04/2002WO2002051807A1 Compounds
07/04/2002WO2002051795A1 Carboxamides, medicaments containing said compounds, use and production thereof
07/04/2002WO2002051397A1 Aniline derivatives or salts thereof and cytokine production inhibitors containing the same
07/04/2002WO2002032856A3 Insecticidal 1,8-naphthalenedicarboxamides
07/04/2002WO2002012149A8 Method for preparing alkoxyamines from nitroxides
07/04/2002WO2001098275A3 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
07/04/2002WO2001016096A3 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
07/04/2002US20020086999 Certain quinoline derivatives
07/04/2002US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates
07/04/2002US20020086887 N-Acylsulfonamide apoptosis promoters
07/04/2002US20020086863 New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds
07/04/2002CA2433520A1 Novel compounds and compositions as cathepsin inhibitors
07/03/2002EP1219614A1 Benzene sulfonamides as PDE-V inhibitors for the use against erectile dysfunction
07/03/2002EP1218341A1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
07/03/2002EP1218336A2 Melanin concentrating hormone antagonist
07/03/2002EP1077912B1 Novel derivatives of 3,3-diphenylpropylamines
07/03/2002EP0563345B1 Novel 4-arylpiperazines and 4-arylpiperidines
07/03/2002CN1356977A Glucagon antagonists/inverse agonists
07/03/2002CN1356324A Process for preparing N-formyl morpholine
07/02/2002US6414020 Antiproteolytic amidino or derivative useful for treating pencreatitis, thrombosis, ischemia, stroke, restenosis, emphysema or inflammation
07/02/2002US6413970 Pharmaceutical composition for treating viral diseases
07/02/2002US6413959 Neurokinin(tachykinin) antagonists
07/02/2002US6413947 Antiinflammatory agents; rheumatic diseases; anticholesterol agents
07/02/2002CA2124315C Nitroaniline derivatives and their use as antitumor agents
07/02/2002CA2018149C Aminoketone compounds
06/2002
06/27/2002WO2002050052A1 N-acyl aminoacetonitriles having pesticidal properties
06/27/2002WO2002050019A2 Diamines as modulators of chemokine receptor activity
06/27/2002WO2002020501A3 Polyarylcarboxamides useful as lipid lowering agents
06/27/2002WO2002018323A3 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors
06/27/2002WO2001096298A3 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
06/27/2002WO2001095856A3 Urea derivative useful as an anti-cancer agent and process for preparing same
06/27/2002US20020082265 For treating or preventing emphysema, cancer and dermatological disorders
06/27/2002US20020082221 Nitric-oxide releasing lipid molecules selected from phosphoglycerides, lipids having a sphingosine base as a backbone, a monoglyceride, a diglyceride, a glycosylacylglycerol and a sterol containing S-N=O, N-N=O or
06/27/2002CA2432908A1 Diamines as modulators of chemokine receptor activity
06/26/2002EP1217000A1 Inhibitors of factor Xa and factor VIIa
06/26/2002EP1216988A1 Thioalkylamine derivatives and process for the preparation thereof
06/26/2002EP1216236A1 Tryptase inhibitors
06/26/2002EP1216229A1 Metallo-organo catalyst for polymerizing unsaturated compounds
06/26/2002EP1216225A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties
06/26/2002EP1216223A1 Novel dicarboxylic acid derivatives with pharmaceutical properties
06/26/2002EP0931067B1 D4 receptor selectivity piperazine derivatives
06/25/2002US6410791 Salbutamol; respiratory system disorders
06/25/2002US6410790 Analgesics
06/25/2002US6410788 Process to produce oxazolidinones
06/25/2002US6410782 Bioavailability; side effect reduction; mixture with an aminoalcohol
06/25/2002US6410781 α-aminoacetic acid derivatives-α4β7 receptor antagonists
06/25/2002US6410594 Viricides
06/25/2002US6410585 Therapy for non-insulin depend diabetes
06/25/2002US6410564 Naphthyl compounds, intermediates, processes, compositions, and methods
06/25/2002US6410532 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
06/25/2002US6410530 Substituted 1,2,3,4-tetrahydronaphthalene derivatives
06/25/2002US6409995 Sunscreen
06/25/2002CA2203878C Certain substituted benzylamine derivatives; a new class of neuropeptide y1 specific ligands
06/20/2002WO2002048179A1 Gamma-ketoacid dipeptide derivatives as inhibitors of caspase-3
06/20/2002WO2002048164A2 Isolation of nucleic acids
06/20/2002WO2002048160A1 Sterically hindered phosphine ligands and uses thereof
06/20/2002WO2002048124A2 Piperazine derivatives
06/20/2002WO2002048122A2 Benzamidine derivatives
06/20/2002WO2002048099A1 Carboxylic acid amide derivatives and their use in the treatment of thromboembolic diseases and tumours
06/20/2002WO2002048097A1 Compounds, compositions and methods for treatment of parasitic infections
06/20/2002WO2002048096A1 Hydrazone derivatives and use thereof in medicines
06/20/2002WO2002048089A1 Process for producing mononitrated aromatic ether compound
06/20/2002WO2002048072A2 Organic reactions with co generating materials
06/20/2002WO2002047679A2 Nonpeptide agonists and antagonists of vasopressin receptors
06/20/2002WO2002016312A3 NOVEL COMPOUNDS INHIBITING FACTOR Xa ACTIVITY
06/20/2002WO2002012214A3 Non-imidazole aryloxyalkylamines as h3 receptor ligands
06/20/2002WO2001083436A3 Small technetium-99m and rhenium labeled agents and methods for imaging tumors
06/20/2002US20020077482 Novel intermediates useful for the preparation of antihistaminic piperidine derivatives
06/20/2002US20020077476 Novel phthalimido arylpiperazines useful in the treatment of benign prostatic hyperplasia
06/20/2002US20020077455 Protease inhibitors